PHARMACOKINETICS AND ORAL BIOAVAILABILITY OF PYRIDOSTIGMINE IN MAN

被引：83

作者：

AQUILONIUS, SM

ECKERNAS, SA

HARTVIG, P

LINDSTROM, B

OSTERMAN, PO

机构：

[1] UNIV UPPSALA HOSP,DEPT PHARM,S-75014 UPPSALA,SWEDEN

[2] NATL BOARD HLTH & WELF,DEPT DRUGS,UPPSALA,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1980年 / 18卷 / 05期

关键词：

D O I：

10.1007/BF00636797

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：423 / 428

页数：6

共 13 条

[1] PHARMACOKINETIC STUDY OF NEOSTIGMINE IN MAN USING GAS CHROMATOGRAPHY-MASS SPECTROMETRY [J].

AQUILONIUS, SM ;

ECKERNAS, SA ;

HARTVIG, P ;

HULTMAN, J ;

LINDSTROM, B ;

OSTERMAN, PO .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (05) :367-371

[2]

BEERMANN B, 1972, EUR J CLIN PHARMACOL, V5, P83

[3]

CALVEY TN, 1977, CLIN PHARMACOL THER, V21, P187

[4] QUANTITATIVE GAS-LIQUID-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF NEOSTIGMINE AND PYRIDOSTIGMINE IN HUMAN-PLASMA [J].

CHAN, K ;

WILLIAMS, NE ;

BATY, JD ;

CALVEY, TN .

JOURNAL OF CHROMATOGRAPHY, 1976, 120 (02) :349-358

[5] RENAL CLEARANCE OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].

CHAN, K ;

CALVEY, TN .

EUROPEAN NEUROLOGY, 1977, 16 (1-6) :69-72

[6]

CHAN K, 1978, CLIN PHARMACOL THER, V22, P596

[7] MALABSORPTION OF PYRIDOSTIGMINE IN PATIENTS WITH MYASTHENIA-GRAVIS [J].

COHAN, SL ;

DRETCHEN, KL ;

NEAL, A .

NEUROLOGY, 1977, 27 (03) :299-301

[8] PHARMACOKINETICS OF PYRIDOSTIGMINE [J].

COHAN, SL ;

POHLMANN, JLW ;

MIKSZEWSKI, J ;

ODOHERTY, DS .

NEUROLOGY, 1976, 26 (06) :536-539

[9] EFFECT OF CHRONIC PYRIDOSTIGMINE ADMINISTRATION ON PYRIDOSTIGMINE-C-14 METABOLISM IN MYASTHENIA GRAVIS [J].

KORNFELD, P ;

WOLF, RL ;

SAMUELS, AJ ;

OSSERMAN, KE .

NEUROLOGY, 1971, 21 (05) :550-&

[10] METABOLISM OF C-14-LABELED PYRIDOSTIGMINE IN MYASTHENIA GRAVIS - EVIDENCE FOR MULTIPLE METABOLITES [J].

KORNFELD, P ;

SAMUELS, AJ ;

WOLF, RL ;

OSSERMAN, KE .

NEUROLOGY, 1970, 20 (07) :634-&

← 1 2 →